help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-0959
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amirouche, A.
Right arrow Articles by Freyssenet, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amirouche, A.
Right arrow Articles by Freyssenet, D.
Endocrinology Vol. 150, No. 1 286-294
Copyright © 2009 by The Endocrine Society

Down-Regulation of Akt/Mammalian Target of Rapamycin Signaling Pathway in Response to Myostatin Overexpression in Skeletal Muscle

Adel Amirouche, Anne-Cécile Durieux, Sébastien Banzet, Nathalie Koulmann, Régis Bonnefoy, Catherine Mouret, Xavier Bigard, André Peinnequin and Damien Freyssenet

Pôle de Recherche et d’Enseignement Supérieur Université de Lyon (A.A., R.B., D.F.), Université Jean Monnet, Laboratoire de Physiologie de l’Exercice, Equipe d’accueil 4338, F-42023 Saint-Etienne, France; Institut d’Anatomie (A.-C.D.), Université de Berne, 3000 Berne, Suisse; and Départment des Facteurs Humains (S.B., N.K., X.B.) et Département de Radiobiologie et Radiopathologie (C.M., A.P.), Centre de Recherche du Service de Santé des Armées, F-38702 La Tronche, France

Address all correspondence and requests for reprints to: Damien Freyssenet, Laboratoire de Physiologie de l’Exercice, Faculté de Médecine, 15 rue Ambroise Paré, 42023 Saint Etienne Cédex 2, France. E-mail: damien.freyssenet{at}univ-st-etienne.fr.

Myostatin, a member of the TGF-β family, has been identified as a master regulator of embryonic myogenesis and early postnatal skeletal muscle growth. However, cumulative evidence also suggests that alterations in skeletal muscle mass are associated with dysregulation in myostatin expression and that myostatin may contribute to muscle mass loss in adulthood. Two major branches of the Akt pathway are relevant for the regulation of skeletal muscle mass, the Akt/mammalian target of rapamycin (mTOR) pathway, which controls protein synthesis, and the Akt/forkhead box O (FOXO) pathway, which controls protein degradation. Here, we provide further insights into the mechanisms by which myostatin regulates skeletal muscle mass by showing that myostatin negatively regulates Akt/mTOR signaling pathway. Electrotransfer of a myostatin expression vector into the tibialis anterior muscle of Sprague Dawley male rats increased myostatin protein level and decreased skeletal muscle mass 7 d after gene electrotransfer. Using RT-PCR and immunoblot analyses, we showed that myostatin overexpression was ineffective to alter the ubiquitin-proteasome pathway. By contrast, myostatin acted as a negative regulator of Akt/mTOR pathway. This was supported by data showing that the phosphorylation of Akt on Thr308, tuberous sclerosis complex 2 on Thr1462, ribosomal protein S6 on Ser235/236, and 4E-BP1 on Thr37/46 was attenuated 7 d after myostatin gene electrotransfer. The data support the conclusion that Akt/mTOR signaling is a key target that accounts for myostatin function during muscle atrophy, uncovering a novel role for myostatin in protein metabolism and more specifically in the regulation of translation in skeletal muscle.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Gilson, O. Schakman, S. Kalista, P. Lause, K. Tsuchida, and J.-P. Thissen
Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin
Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E157 - E164.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. L. Welle
Myostatin and muscle fiber size. Focus on "Smad2 and 3 transcription factors control muscle mass in adulthood" and "Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size"
Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1245 - C1247.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. J. Hulmi, J. Tannerstedt, H. Selanne, H. Kainulainen, V. Kovanen, and A. A. Mero
Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men
J Appl Physiol, May 1, 2009; 106(5): 1720 - 1729.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Welle, K. Burgess, and S. Mehta
Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice
Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E567 - E572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society